4//SEC Filing
Gemphire Therapeutics Inc. 4
Accession 0001596771-17-000007
$MTVACIK 0001638287operating
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 4:25 PM ET
Size
7.5 KB
Accession
0001596771-17-000007
Insider Transaction Report
Form 4
KOUSKY KENNETH W
Director
Transactions
- Other
Common Stock
2017-02-01−110,428→ 6,463 total(indirect: By LLC) - Other
Common Stock
2017-02-01−101,406→ 4,472 total(indirect: By LLC)
Holdings
- 1,000
Common Stock
Footnotes (4)
- [F1]The transaction on this line represents a pro rata distribution by BWA Gemphire Investment Group, LLC ("BWA") to its members without consideration.
- [F2]Mr. Kousky, as the Manager of BWA, beneficially owns the reported securities indirectly.
- [F3]The transaction on this line represents a pro rata distribution by BWA Gemphire Investment Group II, LLC ("BWA II") to its members without consideration.
- [F4]Mr. Kousky, as the Manager of BWA II, beneficially owns the reported securities indirectly.
Documents
Issuer
Gemphire Therapeutics Inc.
CIK 0001638287
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001638287
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 4:25 PM ET
- Size
- 7.5 KB